Latest Financial Health News

Echo IQ Limited reported a modest revenue increase for the half-year ended December 2025, yet its net loss widened significantly, raising questions about its path to profitability.

Saferoads Holdings Limited has reported a return to profitability with a $504k half-year net profit, driven by strong product sales following the sale of its Road Safety Rentals business. The company also announced a fully franked interim dividend of 0.5 cents per share.

Control Bionics Limited reported a sharp increase in losses for the half-year ending December 2025, coinciding with its acquisition of full control over Neuro Elite Athletics, LLC. The company faces ongoing financial challenges despite no dividends being declared.

Black Cat Syndicate has begun processing ore from its Fingals and Majestic mines through the Lakewood Mill and approved a $20 million expansion to boost capacity by 25%, aiming to lower costs and enhance cash flow.

FINEOS Corporation Holdings Plc reported a modest revenue increase for 2025 but swung to a significant net loss, raising questions about its financial trajectory.

Advanced Braking Technology Ltd reported a robust 27.2% revenue increase and a 61.6% rise in net profit for H1 2026, driven by strong international sales and progress in autonomous braking technology.

Bapcor Limited has postponed its half-year financial results release to no later than 27 February 2026 and is seeking an extension of its trading suspension, hinting at a potential capital raising.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

NZME Limited has reported a significant turnaround in 2025, posting a statutory net profit after tax of NZD 13.1 million and a 15% increase in operating EBITDA, underpinned by strong digital revenue growth across its divisions.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.

3D Energi Limited remains suspended from ASX trading after failing to provide a crucial update on its funding status and exploration permit implications, prolonging market uncertainty.

Guzman y Gomez has reported a robust first half of FY26, delivering strong revenue and profit growth alongside significant restaurant network expansion in Australia and the US.